BPGbio to present novel Huntington's Disease and Alzheimer's Disease research at the Society for Neuroscience 2024 annual meeting.

Garmin today announced the Lily® 2 Active ? its latest in the lineup of fashion-forward smartwatches that add built-in GPS and include popular health, wellness and connected features. As Garmin's ...

TeamLogic IT, a national provider of managed IT services and technology support for small and midsize businesses, recently celebrated the franchise ...

UCB taps new UK head. Belgium-based global biopharmaceutical company UCB welcomed Nico Reynders as its new general manager ...

BPM31510IV is also a lead candidate to treat solid tumours such as glioblastoma multiforme and pancreatic cancer.

Boston, Massachusetts Tuesday, October 1, 2024, 14:00 Hrs [IST] ...

BPGbio received an FDA Rare Pediatric Disease Designation for its potential treatment for primary coenzyme Q10 deficiency.

Kyverna Therapeutics named Warner Biddle as CEO. Trailhead Biosystems hired Joshua Snow as chief commercial officer. BPGbio ...

BOSTON--(BUSINESS WIRE)--BPGbio, Inc., a pioneering biology-first, AI-powered, clinical-stage biopharma specializing in mitochondrial biology and protein homeostasis, today announced the ...

BPGbio, Inc., a pioneering biology-first, AI-powered, clinical-stage biopharma specializing in mitochondrial biology and protein homeostasis, today announced the appointment of John Beeler ...

"We are excited to welcome John to our leadership team," said Daniel Elliott, Executive Chairman of BPGbio. "BPGbio has made significant progress on the commercial front in the last 18 months. Dr.